333 related articles for article (PubMed ID: 8378346)
21. Modification of pre-mRNA splicing by antisense oligonucleotides.
Kole R
Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development.
Kang SH; Cho MJ; Kole R
Biochemistry; 1998 May; 37(18):6235-9. PubMed ID: 9572837
[TBL] [Abstract][Full Text] [Related]
23. The conserved dinucleotide AG of the 3' splice site may be recognized twice during in vitro splicing of mammalian mRNA precursors.
Zhuang Y; Weiner AM
Gene; 1990 Jun; 90(2):263-9. PubMed ID: 2401404
[TBL] [Abstract][Full Text] [Related]
24. Intron function in the nonsense-mediated decay of beta-globin mRNA: indications that pre-mRNA splicing in the nucleus can influence mRNA translation in the cytoplasm.
Zhang J; Sun X; Qian Y; Maquat LE
RNA; 1998 Jul; 4(7):801-15. PubMed ID: 9671053
[TBL] [Abstract][Full Text] [Related]
25. High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA.
Vacek MM; Ma H; Gemignani F; Lacerra G; Kafri T; Kole R
Blood; 2003 Jan; 101(1):104-11. PubMed ID: 12393543
[TBL] [Abstract][Full Text] [Related]
26. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.
Takeshima Y; Nishio H; Sakamoto H; Nakamura H; Matsuo M
J Clin Invest; 1995 Feb; 95(2):515-20. PubMed ID: 7860733
[TBL] [Abstract][Full Text] [Related]
27. A single-base change at a splice site in a beta 0-thalassemic gene causes abnormal RNA splicing.
Treisman R; Proudfoot NJ; Shander M; Maniatis T
Cell; 1982 Jul; 29(3):903-11. PubMed ID: 7151176
[TBL] [Abstract][Full Text] [Related]
28. Intron sequences and the length of the downstream second exon affect the binding of hnRNP C proteins in an in vitro splicing reaction.
Goswami P; Goldenberg CJ
Nucleic Acids Res; 1988 Jun; 16(11):4995-5011. PubMed ID: 3290845
[TBL] [Abstract][Full Text] [Related]
29. Inverse splicing of a discontinuous pre-mRNA intron generates a circular exon in a HeLa cell nuclear extract.
Braun S; Domdey H; Wiebauer K
Nucleic Acids Res; 1996 Nov; 24(21):4152-7. PubMed ID: 8932365
[TBL] [Abstract][Full Text] [Related]
30. The studies of hemoglobinopathies and thalassemia in China--the experiences in Shanghai Institute of Medical Genetics.
Zeng Y; Huang S
Clin Chim Acta; 2001 Nov; 313(1-2):107-11. PubMed ID: 11694246
[TBL] [Abstract][Full Text] [Related]
31. Sequence of the polypyrimidine tract of the 3'-terminal 3' splicing signal can affect intron-dependent pre-mRNA processing in vivo.
Liu X; Mertz JE
Nucleic Acids Res; 1996 May; 24(9):1765-73. PubMed ID: 8649998
[TBL] [Abstract][Full Text] [Related]
32. Interplay between U2 snRNP and 3' splice factor(s) for branch point selection on human beta-globin pre-mRNA.
Alibert C; Tazi J; Temsamani J; Jeanteur P; Brunel C; Cathala G
Nucleic Acids Res; 1990 Jan; 18(2):235-45. PubMed ID: 2139208
[TBL] [Abstract][Full Text] [Related]
33. Cryptic branch point activation allows accurate in vitro splicing of human beta-globin intron mutants.
Ruskin B; Greene JM; Green MR
Cell; 1985 Jul; 41(3):833-44. PubMed ID: 3879973
[TBL] [Abstract][Full Text] [Related]
34. A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia.
Vidaud M; Gattoni R; Stevenin J; Vidaud D; Amselem S; Chibani J; Rosa J; Goossens M
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1041-5. PubMed ID: 2915972
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of pre-mRNA splicing by antisense RNA in vitro: effect of RNA containing sequences complementary to introns.
Volloch V; Schweitzer B; Rits S
Biochem Biophys Res Commun; 1991 Sep; 179(3):1600-5. PubMed ID: 1930200
[TBL] [Abstract][Full Text] [Related]
36. Nuclear degradation of nonsense mutated beta-globin mRNA: a post-transcriptional mechanism to protect heterozygotes from severe clinical manifestations of beta-thalassemia?
Kugler W; Enssle J; Hentze MW; Kulozik AE
Nucleic Acids Res; 1995 Feb; 23(3):413-8. PubMed ID: 7885837
[TBL] [Abstract][Full Text] [Related]
37. Beta-thalassemia resulting from a single nucleotide substitution in an acceptor splice site.
Atweh GF; Anagnou NP; Shearin J; Forget BG; Kaufman RE
Nucleic Acids Res; 1985 Feb; 13(3):777-90. PubMed ID: 2987809
[TBL] [Abstract][Full Text] [Related]
38. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.
Schmajuk G; Sierakowska H; Kole R
J Biol Chem; 1999 Jul; 274(31):21783-9. PubMed ID: 10419493
[TBL] [Abstract][Full Text] [Related]
39. Nuclear pre-mRNA processing in plants: distinct modes of 3'-splice-site selection in plants and animals.
Wiebauer K; Herrero JJ; Filipowicz W
Mol Cell Biol; 1988 May; 8(5):2042-51. PubMed ID: 3386632
[TBL] [Abstract][Full Text] [Related]
40. The length of the downstream exon and the substitution of specific sequences affect pre-mRNA splicing in vitro.
Furdon PJ; Kole R
Mol Cell Biol; 1988 Feb; 8(2):860-6. PubMed ID: 3352607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
